News

Date:
Luminary Mark Prausnitz, PhD Georgia Tech, School of Chemical & Biomolecular Engineering Regents Professor, J. Erskine Love Jr. Chair in Chemical & Biomolecular Engineering, and Director of the Center for Drug Design, Development and Delivery   1. What sparked your interest in science…
Date:
2017 DDTR Parameters DDTR, an official journal of CRS, continues to improve the quality of published papers that are particularly focused on translational aspects of drug delivery science and technology. The journal also encourages submissions that are innovative and address critical drug delivery…
Date:
Over the past decades, demand for natural resources has accelerated to the extent that it is now widely considered a serious threat to the proper functioning of economies and societies owing to associated environmental problems such as climate change, biodiversity loss, desertification, and…
Authors:
Date:
Business Wire: September 14, 2017 – CAMBRIDGE, MA, U.S.A. – Seqirus announced today that the U.S. Food and Drug Administration (FDA) has approved Afluria Quadrivalent (influenza vaccine) for use in people five years of age and older, extending the company’s broad portfolio of influenza vaccine…
Date:
BOCA RATON, FL, U.S.A. – TherapeuticsMD, Inc. (NYSE American: TXMD), an innovative women’s healthcare company, today announced the submission of the additional endometrial safety information that was requested by the Food and Drug Administration (FDA) in its recent General Advice Letter to the…
Date:
Business Wire: September 14, 2017 – BOSTON, MA, U.S.A., and PFÄFFIKON, Switzerland – Intarcia Therapeutics, Inc., and Numab Therapeutics AG today announced the achievement of a key milestone in their ongoing development partnership—the selection of a multispecific antibody construct targeting…